cancer

After her double mastectomy, writer Catherine Guthrie came to embrace her new body, without breast reconstruction. But, she has learned, women have to push the medical system to support this choice.

A research start-up is connecting parents with scientists in hopes of sparking new research on diseases whose survival rates and treatment options haven't budged in 30 years

After trying one treatment after another for his leukemia, 20-year old Aaron Reid enrolled in a study to test an experimental therapy using modified cells from his own body.

Thousands of people died as a result of the earthquake and tsunami that hit in 2011, but this is the first death that the government says was caused by radiation. He was a Fukushima worker.

A court in California ruled that coffee sellers must put a warning label on their products, but the federal regulator endorsed a proposal to exempt them from state law.

In a new study, researchers found that doctors are better at explaining the benefits of a common cancer screening that its potential downsides. But overtesting comes with risks and costs of its own.

Researchers are working on better ways to teach patients' immune systems to root out and kill malignant cells. A promising approach involves cells that attack cancer two ways at one time.

A tiny accelerator could be useful in medicine as well as basic science. Instead of speeding up beams of electrons through giant tunnels, the aim here is to build accelerators on semiconductor chips.

Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.

The verdict, reportedly the largest ever in such a case, was awarded to 22 women and their families who claim asbestos in the powder contributed to their ovarian cancer. The company plans an appeal.

Cancer death rates remain high for some groups of people, including African-Americans, despite general gains made in recent decades. The American Cancer Society has ideas about reducing the gaps.

A Harvard Medical School project aims to become the first national registry for exceedingly rare cancer patients who respond mysteriously well to treatments that failed to help others.